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Background and aims: This study examined associations between leisure-time physical activity (LTPA)
across adulthood (from age 36) and cardiovascular disease (CVD) biomarkers at age 60e64.
Methods: LTPA was reported by study participants from the MRC National Survey of Health and Devel-
opment at ages 36, 43, 53 and 60e64 (n ¼ 1754) and categorised as inactive, moderately active (1e4/
month) or most active (5þ/month) at each age. Linear regression was used to examine associations
between a cumulative adulthood LTPA score (range ¼ 0e8), and change in LTPA between ages 36 and 60
e64 (i.e. always inactive, became inactive, became active, always active) and inﬂammatory [C-reactive
protein (CRP), interleukin-6 (IL-6)], endothelial [tissue-Plasminogen Activator (t-PA), E-selectin] and
adipokine [leptin, adiponectin] measures extracted from overnight fasting blood samples at age 60e64.
Results: The more active a participant was over adulthood, the better their biomarker proﬁle, e.g. fully-
adjusted difference in t-PA (both sexes) and adiponectin (women) per unit increase in the LTPA score
(95% conﬁdence interval) ¼ 2.2% (3.6; 0.8) and 2.0% (0.2; 3.8). Those that became active at age 60
e64 showed slightly healthier biomarker proﬁles than those that became inactive [e.g. fully-adjusted
difference in IL-6 ¼ 9.9% (23.9; 4.1) vs. 3.8% (12.4; 4.8)], although the best proﬁles were seen
for those always active [IL-6: 15.0% (24.2; 5.7)], when compared with the always inactive group.
Conclusions: Greater accumulation of LTPA across adulthood was associated with a more favourable CVD
biomarker proﬁle in early old age. Earlier uptake and long-term maintenance of LTPA may provide the
greatest beneﬁts for CVD prevention.
© 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Leisure-time physical activity (LTPA) of moderate-to-vigorous
intensity has consistently been shown to lower risk of cardiovas-
cular disease (CVD) [1,2] and premature mortality from CVD [2e4];
the world's leading cause of death [5e7]. The mechanisms under-
lying the relationships between LTPA and CVD outcomes are not
fully understood, but are thought to be partly due to beneﬁcial
effects of physical activity on endothelial function and emergingUnit, Translational Health
evel 1 Learning and Research
eem).
d are joint ﬁrst authors.
r Ireland Ltd. This is an open acces
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erosclerosis (2017), https://dbiomarkers of atherosclerosis, such as inﬂammatory markers and
adipokines [8e15].
Evidence of how physical activity impacts atherosclerotic bio-
markers is primarily based on intervention studies. Most widely
investigated are the anti-inﬂammatory effects of physical activity
with consistent ﬁndings of decreases in C-reactive protein (CRP)
and interleukin-6 (IL-6) following brief exercise interventions
[11,12]. Intervention studies also suggest that exercise-induced fat
loss can lower leptin and increase adiponectin levels [8]. Physical
activity has also been reported to improve the endothelium's ability
to release tissue-plasminogen activator (t-PA) but its effects on E-
selectin are unclear [9].
These short-term intervention studies are unable to provide
evidence on whether beneﬁts of LTPA remain in the longer term
and whether changes in LTPA across life are associated with theses article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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sociations between patterns of physical activity across adulthood
and CVD biomarkers. For example, 60-79 year-old men from the
British Regional Heart study (BRHS), who increased LTPA from
baseline levels reported four [16] and twenty [17] years earlier, had
lower CRP and t-PA than those least active at both assessments, and
similar t-PA but higher CRP when compared with men who were
most active at both time points [16,17]. Likewise, ﬁndings from the
Whitehall II Study showed that, over a 10-year period, both
consistent, and improvements in, adherence to recommended LTPA
(2.5 h/week of moderate-to-vigorous physical activity) were asso-
ciated with lower levels of pro-inﬂammatory markers (CRP and IL-
6) [18].
However, studies with longer follow-up and more repeated
assessments of LTPA over follow-up and, those which consider in-
ﬂammatory as well as other biomarkers of CVD are needed to
investigate how beneﬁts of LTPA might accumulate across adult-
hood, and how changes in LTPA might inﬂuence CVD biomarkers.
The aim of this study was therefore to investigate associations
between LTPA assessed four times over 28 years in adulthood with
inﬂammatory, endothelial and adipokinemarkers of CVDmeasured
in early old age.We hypothesised that greater LTPA at each age, and
greater accumulation of LTPA would be associated with more
favourable CVD biomarker concentrations at age 60e64, and that
those who become active would have more favourable levels than
those who remained inactive.
2. Materials and methods
2.1. Study design
The MRC National Survey of Health and Development (NSHD) is
a British cohort of 5362 men and women followed up since birth in
March 1946 [19,20]. Between 2006 and 2010 (at age 60e64), a total
of 2856 eligible study members (those still alive and with a known
address in England, Scotland or Wales) were invited to a clinical
research facility (CRF) assessment, or to be visited by a research
nurse at home. Invitations were not sent to those who had died
(n ¼ 778), emigrated (n ¼ 570), previously withdrawn from the
study (n ¼ 594) or were lost to follow-up (n ¼ 564). Of those
invited, 2229 (78%) were assessed: 1690 attended a CRF and 539
were seen at home [21].
Ethical approval was obtained from the Greater Manchester
Local Research Ethics Committee and the Scotland A Research
Ethics Committee. Written, informed consent was obtained from
study members for each component of the data collection.
2.2. Measurement of adipokines, endothelial and inﬂammatory
markers at age 60-64
Overnight fasting blood samples were taken during the clinical
assessment and initially processed at the CRF laboratories. Aliquots
were frozen and stored prior to being transferred to the MRC Hu-
man Nutrition Research laboratory in Cambridge where analyses of
inﬂammatory marker CRP was processed according to standardised
protocols. Analyses of adipokines (leptin and adiponectin), endo-
thelial markers (E-selectin and t-PA) and inﬂammatory marker IL-6
were undertaken by British Heart Foundation Research Centre in
Glasgow. The method and commercial assay plus interassay co-
efﬁcients of variation are given in Supplementary Data 1.
2.3. Adulthood leisure time physical activity (LTPA)
LTPA was reported at ages 36, 43, 53 and 60e64. At age 36,
participants were asked how often in the previous month they hadPlease cite this article in press as: A. Elhakeem, et al., Leisure-time physical
age 60e64: A prospective cohort study, Atherosclerosis (2017), https://dparticipated in 27 different leisure-time activities using a modiﬁed
Minnesota LTPA questionnaire [22,23]. At age 43, information was
collected on participation in sports, exercise or other vigorous lei-
sure activities in the previous year including for howmany months
and how often in those months activities were performed [22]. At
ages 53 and 60e64, participants reported howoften in the previous
4 weeks they participated in any sports, vigorous leisure activities
or exercises [22]. At each age, participants were classiﬁed as inac-
tive if they reported no participation, moderately active if they
participated up to four times, or most active if they participated ﬁve
or more times in LTPA (in the previous month at age 36, per month
at age 43 and in the previous 4 weeks at ages 53 and 60e64) [22].
2.4. Covariates
The following covariates were identiﬁed a priori for inclusion in
analyses as they are likely to be associated with both LTPA and CVD
biomarkers. Body mass index (BMI) (kg/m2) was calculated using
heights and weights measured by nurses at age 60e64. Smoking
history reported up to age 60e64 was categorised as never smoked,
ex-smoker or current smoker. The Registrar General's occupational
class at age 53 (or earlier if missing) was used as indicator of so-
cioeconomic position (SEP) and categorised as professional and
intermediate (I&II); skilled non-manual (IIINM); skilled manual
(IIIM); and semi-skilled and unskilled manual (IV&V). At age
60e64, doctor diagnoses of diabetes, stroke, angina and myocardial
infarction were reported, and hypertension (blood pressure  140/
90) was assessed by research nurses using an Omron device.
2.5. Statistical analysis
All inﬂammatory (CRP and IL-6) and endothelial (E-selectin and
t-PA) markers and adipokines (adiponectin and leptin) were posi-
tively skewed and therefore transformed using the natural loga-
rithm. Sex differences in associations between LTPA at each age and
each biomarker were investigated by testing interactions between
sex and LTPA using likelihood ratio tests, with sex-stratiﬁed ana-
lyses performed where evidence of interaction was found.
First, linear regression models were used to examine associa-
tions between LTPA at each age and each CVD biomarker (at age
60e64). Second, LTPA responses from ages 36, 43, 53 and 60e64
(coded at each age as 0 ¼ inactive, 1 ¼moderately active, 2 ¼most
active) were summed to derive a cumulative adulthood LTPA score
ranging from 0 (inactive at each age) to 8 (most active at each age)
to examine its associations with biomarkers. Deviation from line-
arity was tested by comparing models with the LTPA score entered
as a continuous and as a categorical variable. We tested whether
the cumulative LTPA score added information about variation in
biomarkers over and above LTPA at 60e64 by using likelihood ratio
tests to compare a baselinemodel including only LTPA at age 60e64
to models with the added cumulative LTPA score.
As study members could be allocated the same cumulative LTPA
score despite having different adulthood patterns of LTPA (i.e.
having become either more active or inactive), thirdly, we exam-
ined associations of change in LTPA by classifying participants
based on whether they reported any LTPA at ages 36 and 60e64 as
always inactive, always active, became inactive or became active. In
this model with LTPA at both ages, we used an interaction term
(LTPA at 36 by LTPA at 60e64) to test for deviation from an additive
effect. We tested whether change in LTPA between 36 and 60e64
improved model ﬁt by using likelihood ratio tests to compare a
baseline model of LTPA at age 60e64 to models with added terms
for LTPA at age 36 and the interaction term for LTPA at ages 36 and
60e64.
Age and sex-adjusted differences from the two accumulationactivity across adulthood and biomarkers of cardiovascular disease at
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Table 1
Characteristics of study participants from the MRC National Survey of Health and Development with at least one leisure-time physical activity (LTPA) and biomarker measure
and data on covariates.
Overall (n ¼ 1754) Men (n ¼ 858) Women (n ¼ 896) p from sex-difference test
Mean biomarker levels
Inﬂammatory markers
C-reactive protein (mg/l) 3.9 3.8 (0.3) 3.9 (0.3) 0.7
Interleukin-6 (pg/ml) 2.8 2.9 (0.1) 2.6 (0.09) 0.08
Endothelial markers
Tissue-plasminogen activator (ng/ml) 10.0 10.7 (0.2) 9.4 (0.2) <0.001
E-selectin (ng/ml) 39.4 41.4 (0.7) 37.5 (0.6) <0.001
Adipokines
Leptin (ng/ml) 18.9 10.1 (0.3) 27.1 (0.9) <0.001
Adiponectin (mg/ml) 15.0 10.7 (0.3) 19.1 (0.4) <0.001
LTPA at each age in adulthood
Age 36 0.002
Inactive 538 (33.3) 42.4 57.6
Moderately active 456 (28.2) 51.8 48.3
Most active 624 (38.6) 51.7 48.2
Age 43 0.001
Inactive 812 (48.4) 45.0 55.1
Moderately active 424 (25.3) 47.6 52.4
Most active 441 (26.3) 56.2 43.8
Age 53 0.3
Inactive 746 (44.3) 46.4 53.6
Moderately active 333 (19.8) 51.1 49.0
Most active 606 (36.0) 49.0 51.0
Age 60-64 0.4
Inactive 1088 (62.8) 50.0 50.0
Moderately active 245 (14.1) 46.1 53.9
Most active 399 (23.0) 47.4 52.6
Mean adulthood LTPA score 3.33 (0.06) 3.45 (0.09) 3.21 (0.08) 0.04
LTPA change between 36 and 60e64 <0.001
Inactive at both ages 413 (25.8) 45.5 54.5
Became inactive at 60-64 596 (37.3) 53.4 46.6
Became active at 60-64 120 (7.5) 31.7 68.3
Active at both ages 470 (29.4) 49.8 50.2
Mean (SE) for continuous data and % for categorical data. LTPA classiﬁed from how often in the previous month or 4 weeks they had participated in any sports, vigorous leisure
activities or exercises: inactive (0 times), moderately active (1e4 times), most active (5 times).
A. Elhakeem et al. / Atherosclerosis xxx (2017) 1e9 3models, the second and third analyses described in the previous
paragraph, were adjusted in steps for covariates (i.e. SEP, smoking
history, BMI, CVD, stroke and diabetes and hypertension). Results
were presented as percentage differences since outcomes are log-
ged [24]. Analyses were carried out in STATA 14 (StataCorp, Texas).2.6. Additional and sensitivity analyses
To identify which covariates caused the greatest attenuations in
estimates, models were reﬁtted with adjustment in turn for each
covariate. To examine mediation by adiposity, we reﬁtted ﬁnal
models before and after adjustment for BMI. We explored residual
confounding by earlier BMI by reﬁtting ﬁnal models with adjust-
ment for BMI at ages 53 and 60e64. To assess the extent of reverse
causality whereby those with existing CVD and health problems
participate less in LTPA, we repeated analyses after excluding
prevalent CVD and diabetes, and reﬁtted ﬁnal models before and
after adjustment for long-term illness, health problems or disability
that limits activity (reported at age 60e64). To examine potential
effects of diet over and above those of SEP and BMI, ﬁnal models
were reﬁtted before and after adjustment for a marker of healthy
diet, the Eating Choices Index, derived from ﬁve-day food fre-
quency diaries from a subsample of participants at age 60e64 [25].
Additionally, CRP analyses were repeated after excluding levels
>10 mg/l (as these could indicate an acute infection), and further
models were also ﬁtted with adjustment for medication use (b-
blockers and lipid lowering drugs) at age 60e64. Finally, to inves-
tigate bias due to missing data, models were reﬁtted using multiple
imputation to account for missing covariates and LTPA. In each case,Please cite this article in press as: A. Elhakeem, et al., Leisure-time physical
age 60e64: A prospective cohort study, Atherosclerosis (2017), https://d20 imputed data sets were obtained via chained equations and
estimates were combined using Rubin's rules [26].3. Results
3.1. Descriptive statistics
Of 2229 participants with a clinic or home visit at 60e64 years,
2078 (93.2%) had data on at least one CVD biomarker. A further two
participants were excluded for not having any LTPAmeasures at any
adult age and 322 for incomplete data on covariates, leaving a total
of 1754 participants (51.1% female) with data on least one measure
of LTPA and one or more biomarker in addition to complete data on
all covariates (Table 1). When comparedwith those excluded due to
missing data on biomarkers, higher proportions of those with data
on one or more biomarker were female (51.1% vs. 45.7%) and in
occupational classes I&II (49.4% vs. 33.5%) while lower proportions
were current smokers (10.8% vs. 14.9%) and had diabetes (6.8% vs.
9.7%). Thosewith data on one ormore biomarkers weremore active
in LTPA across adulthood (e.g. mean adulthood LTPA scores¼ 3.4 vs.
3.0) but there were no differences by BMI, hypertension, or CVD
diagnoses.
Women had higher levels of adipokines (adiponectin and leptin)
than men, while men had higher levels of endothelial markers E-
selectin and t-PA (Table 1). A greater proportion of participants
were moderately or most active in LTPA at age 36, with higher
proportions reporting no LTPA at older ages. More women were
inactive at ages 36 and 43 but higher proportions of men became
inactive over subsequent follow-up assessments; resulting inactivity across adulthood and biomarkers of cardiovascular disease at
oi.org/10.1016/j.atherosclerosis.2017.11.019
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inactive at age 60e64 (Table 1).
3.2. LTPA from age 36 and inﬂammatory markers (CRP and IL-6) at
age 60-64
At all ages, more frequent LTPAwas related to lower CRP and IL-Fig. 1. Mean percentage difference in biomarkers at age 60e64 by leisure time physical activ
age and sex and adipokines adjusted for age.
Reference: no LTPA. Square: moderate LTPA (1e4 times per month). Triangle: most LTPA (5
Please cite this article in press as: A. Elhakeem, et al., Leisure-time physical
age 60e64: A prospective cohort study, Atherosclerosis (2017), https://d6 at age 60e64 when compared with no LTPA; there was a trend
across groups such that the most active also had lower levels than
the moderately active (Fig. 1). For CRP, LTPA at 36 and the interac-
tion between LTPA at 36 and 60e64, and cumulative LTPA score, led
to an improved model ﬁt when compared with a model which only
included current LTPA (Supplementary Data 3). For IL-6, improve-
ment in model ﬁt was greater for the cumulative LTPA score thanity (LTPA) at each age in adulthood. Inﬂammatory and endothelial markers adjusted for
þ times per month). *Sex interaction (p  0.05).
activity across adulthood and biomarkers of cardiovascular disease at
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60e64) was related to lower CRP and IL-6, and associations were
attenuated but not entirely explained by adjustment for covariates
(Table 2). Evidence of deviation from linearity was found when
examining the association between this cumulative LTPA score and
IL-6 (p ¼ 0.02); additional investigations revealed that, when
compared with an LTPA score of 0e2 (least active across adult-
hood), those with scores of 5e6 and 7e8 but not 3e4 had lower IL-
6. Similarly, when compared with those always inactive at ages 36
and 60e64, those active in LTPA at both ages had lower CRP and IL-
6 even after adjustment for covariates (Table 4). Participants that
‘became active’ or ‘became inactive’ had intermediate levels be-
tween the ‘always active’ and ‘always inactive’ groups, with those
becoming active having slightly better levels than those becoming
inactive (Table 4).
3.3. LTPA from age 36 and endothelial markers (t-PA and E-selectin)
at age 60-64
More frequent LTPA at each age was related to lower t-PA at age
60e64 when compared with reporting no LTPA, whereas greater
LTPA at ages 53 and 60e64 was related to lower E-selectin (Fig. 1).
Like the inﬂammatory markers, groups that were most active had
lower levels than the moderately active (Fig. 1). For t-PA, but not E-
selectin, the cumulative LTPA score led to an improved model ﬁt
when compared with a model that only included concurrent LTPA
(Supplementary Data 3). Change in LTPA did not add information
for either biomarker (Supplementary Data 3). Cumulative exposure
to higher LTPA across adulthood (from age 36 to 60e64) was related
to lower t-PA; with associations not entirely explained by adjust-
ment for covariates (Table 2). Accumulation of LTPA across adult-
hood was weakly associated with lower E-selectin, with this
association attenuated after adjustment (Table 2). When examining
change in LTPA between ages 36 and 60e64, those active at both
ages had lower t-PA levels, compared with those always inactive;
even after adjustment for covariates (Table 4). The ‘became active’
had intermediate t-PA levels between the ‘always active’ and ‘al-
ways inactive’ groups while the ‘became inactive’ group had t-PA
levels like the ‘always inactive’ group. Change in LTPA between 36Table 2
Mean percentage difference (95% conﬁdence intervals) in inﬂammatory and endothelial m
adulthood.
Inﬂammatory markers
C-reactive protein (mg/l)
(n ¼ 1510)
p Interleukin-6 (pg/ml)
(n ¼ 1506)
p
Adulthood LTPA score (0e8): per 1-unit increase
Model 1 4.6 (6.4, 2.7) <0.001 5.0 (6.5, 3.5) <0.001
Model 2 2.4 (4.3, 0.6) 0.01 3.5 (5.0, 2.0) <0.001
Model 3 2.4 (4.3, 0.6) 0.01 3.4 (4.9, 1.9) <0.001
Model 1: adjusted for age and sex. Model 2 also adjusted for body mass index, smoking
hypertension, diabetes, stroke, angina, myocardial infarction. Evidence of deviation from
Table 3
Mean percentage difference (95% conﬁdence intervals) in adipokines at age 60e64 by ac
Leptin (ng/ml)
Men (n ¼ 724) p Women (n ¼ 783) p -
Adulthood LTPA score (0e8): per 1-unit increase
Model 1 3.9 (6.3, 1.6) 0.001 7.8 (10.1, 5.5) <0
Model 2 4.4 (6.2, 2.6) <0.001 2.4 (4.2, 0.6) 0.0
Model 3 4.2 (6.0, 2.4) <0.001 2.4 (4.2, 0.5) 0.0
Model 1: adjusted for age. Model 2 also adjusted for body mass index, smoking history an
diabetes, stroke, angina, myocardial infarction. Evidence of deviation from linearity was
Please cite this article in press as: A. Elhakeem, et al., Leisure-time physical
age 60e64: A prospective cohort study, Atherosclerosis (2017), https://dand 60e64 was not associated with E-selectin (Table 4).
3.4. LTPA from age 36 and adipokines (leptin and adiponectin) at
age 60-64
Associations between LTPA and adipokines differed by sex
(Supplementary Data 2) so analyses for these outcomes were pre-
sented separately for men and women. More frequent LTPA at all
ages was associated with lower leptin and higher adiponectin in
women whereas for men, only LTPA at ages 53 and 60e64 was
associated with leptin, and no associations were found with adi-
ponectin (Fig. 1). The cumulative LTPA score (but not LTPA change
from 36) led to an improved model ﬁt over and above current LTPA
for both leptin and adiponectin (Supplementary Data 3). Using
accumulation models, greater LTPA across adulthood was associ-
ated with lower leptin in men and, more strongly, in women, and
with higher adiponectin in women only (Table 3). These associa-
tions were slightly attenuated, but not fully explained, after
adjustment. Evidence of deviation from linearity was found be-
tween the adult LTPA score and leptin in men (p ¼ 0.009). Addi-
tional investigations revealed that, when compared with an LTPA
score of 0e2 (least active across adulthood), those with scores of
5e6 and 7e8 but not 3e4 had lower leptin levels.
When compared with ‘always inactive’ at 36 and 60e64, those
who participated in LTPA at both ages had lower leptin levels even
after adjustment for covariates (Table 4). Groups that ‘became
active’ or ‘became inactive’ had intermediate levels between the
‘always active’ and ‘always inactive’ groups (Table 4). Onlymenwho
were active at both ages had lower leptin levels than those inactive
at both ages (p ¼ 0.09 for LTPA at age 36 by LTPA at age 60e64
interaction term). Women who remained active and, to a lesser
extent, women who became active had higher adiponectin than
those ‘always inactive’ but differences were reduced by adjustment
(Table 4).
3.5. Additional and sensitivity analyses
The greatest reductions in biomarker differences were seen after
adjustment for BMI, smoking history and SEP (model 2 inarkers at age 60e64 by accumulation of leisure-time physical activity (LTPA) across
Endothelial markers
Tissue plasminogen activator (ng/ml)
(n ¼ 1324)
p E-selectin (ng/ml)
(n ¼ 1506)
p
2.9 (4.3, 1.6) <0.001 1.0 (2.0, 0.1) 0.03
2.3 (3.7, 0.9) 0.002 0.4 (1.4, 0.5) 0.4
2.2 (3.6, 0.8) 0.002 0.4 (1.3, 0.6) 0.4
history and socioeconomic position. Model 3: as for model 2 plus adjustment for
linearity was found between the adult LTPA score and interleukin-6 (p ¼ 0.02).
cumulation of leisure-time physical activity (LTPA) across adulthood.
Adiponectin (ug/ml)
value Men (n ¼ 723) p Women (n ¼ 783) p -value
.001 0.6 (2.7, 1.5) 0.5 4.2 (2.4, 6.0) <0.001
1 0.8 (3.0, 1.3) 0.4 2.1 (0.3, 3.9) 0.02
1 1.1 (3.2, 1.1) 0.3 2.0 (0.2, 3.8) 0.03
d socioeconomic position. Model 3: as for model 2 plus adjustment for hypertension,
found between the adult LTPA score and leptin in men (p ¼ 0.009).
activity across adulthood and biomarkers of cardiovascular disease at
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Table 4
Mean percentage difference (95% conﬁdence intervals) in biomarkers at age 60e64 by change in leisure-time physical activity (LTPA) between ages 36 and 60e64.
Always inactive Became inactive Became active Always active p (overall association)
C-reactive protein (n ¼ 1592)
Model 1 0.0 13.2 (24.2, 2.2) 20.6 (38.4, 2.8) 27.9 (39.5, 16.3) <0.001
Model 2 0.0 7.5 (18.1, 3.0) 8.5 (25.7, 8.7) 15.6 (27.0, 4.2) 0.06
Model 3 0.0 7.7 (18.3, 2.9) 8.5 (25.7, 8.7) 15.6 (27.0, 4.1) 0.07
Interleukin-6 (n ¼ 1585)
Model 1 0.0 8.6 (17.4, 0.3) 20.3 (34.6, 5.9) 25.2 (34.5, 15.9) <0.001
Model 2 0.0 4.0 (12.6, 4.6) 10.3 (24.3, 3.7) 15.7 (24.9, 6.4) 0.005
Model 3 0.0 3.8 (12.4, 4.8) 9.9 (23.9, 4.1) 15.0 (24.2, 5.7) 0.009
Tissue plasminogen activator (n ¼ 1388)
Model 1 0.0 0.9 (7.3, 9.1) 5.0 (18.1, 8.0) 12.5 (21.0, 4.0) 0.004
Model 2 0.0 2.8 (5.2, 10.9) 0.8 (13.8, 12.1) 7.8 (16.3, 0.8) 0.05
Model 3 0.0 2.7 (5.4, 10.8) 1.2 (14.2, 11.7) 7.8 (16.3, 0.8) 0.06
E-selectin (n ¼ 1585)
Model 1 0.0 1.9 (7.6, 3.7) 5.0 (14.1, 4.2) 5.8 (11.7, 0.2) 0.2
Model 2 0.0 0.0 (5.6, 5.5) 1.3 (10.3, 7.7) 1.7 (7.7, 4.2) 0.9
Model 3 0.0 0.1 (5.5, 5.6) 1.5 (10.5, 7.5) 1.5 (7.5, 4.4) 0.9
Leptin e men (n ¼ 771)
Model 1 0.0 8.3 (5.4, 22.0) 1.3 (25.4, 28.0) 16.1 (30.6, 1.5) 0.003
Model 2 0.0 0.4 (10.8, 10.0) 2.4 (22.7, 18.0) 19.5 (3.7, 8.3) <0.001
Model 3 0.0 0.5 (10.9, 9.9) 1.1 (21.3, 19.1) 18.3 (29.5, 7.2) 0.001
Leptin e women (n ¼ 815)
Model 1 0.0 11.5 (25.3, 2.4) 28.4 (48.4, 8.4) 42.7 (57.3, 28.2) <0.001
Model 2 0.0 7.4 (2.9 17.7) 1.2 (16.2, 13.7) 10.7 (21.9, 0.4) 0.007
Model 3 0.0 7.3 (3.0, 17.7) 1.3 (16.2, 13.7) 10.6 (21.7, 0.6) 0.008
Adiponectin e men (n ¼ 770)
Model 1 0.0 0.9 (11.7, 13.4) 14.5 (38.9, 9.9) 6.5 (19.8, 6.8) 0.4
Model 2 0.0 2.9 (9.5, 15.4) 15.1 (39.3, 9.2) 7.5 (20.9, 5.9) 0.2
Model 3 0.0 1.6 (10.6, 14.0) 17.2 (41.1, 6.8) 10.2 (23.5, 3.0) 0.1
Adiponectin e women (n ¼ 815)
Model 1 0.0 7.5 (3.1, 18.0) 18.3 (3.1, 33.6) 21.5 (10.4, 32.5) <0.001
Model 2 0.0 0.1 (10.1, 10.4) 7.5 (7.4, 22.3) 8.9 (2.2, 19.9) 0.3
Model 3 0.0 0.6 (10.9, 9.6) 7.9 (7.0, 22.7) 8.2 (2.8, 19.3) 0.3
Model 1: adjusted for age (and sex). Model 2 also adjusted for body mass index, smoking history and socioeconomic position. Model 3: as for model 2 plus adjustment for
hypertension, diabetes, stroke, angina, myocardial infarction. There was no evidence of age 36 by age 60e64 LTPA interactions, except for a suggestion of an interaction for
leptin in men (p ¼ 0.09).
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attenuation in estimates, suggesting associations were predomi-
nantly mediated by adiposity. Adjustment for BMI recorded at ages
53 and 60e64 had no inﬂuence on ﬁndings. Results were similar
after adjustment for long-term limiting illness (Supplementary
Data 4) and after exclusion of participants with CVD and diabetes
(n ¼ 233). Additional adjustment for diet had little inﬂuence on
associations (Supplementary Data 5). Excluding CRP levels >10 mg/
l (n ¼ 230), and further adjustment for medication use (up to 200
participants were taking b-blockers and 400 taking lipid lowering
drugs) also did not inﬂuence ﬁndings. Lastly, similar results were
found after multiple imputation (Supplementary Data 6).
4. Discussion
4.1. Main ﬁndings
Findings from this British cohort study showed that greater
participation in LTPA over 28 years across adulthoodwas associated
withmore favourable levels of CVD biomarkers in early old age, and
highlight the added value of prior LTPA for explaining variations in
biomarkers over current LTPA alone. More frequent LTPA at ages 36,
43, 53 and 60e64, and therefore greater accumulation of LTPA
across adulthood, was associated with lower CRP, IL-6, t-PA andPlease cite this article in press as: A. Elhakeem, et al., Leisure-time physical
age 60e64: A prospective cohort study, Atherosclerosis (2017), https://dleptin levels in both men and women, and higher adiponectin
levels inwomen only. Consistent with a model of accumulation, the
‘always active’ group showed the best biomarker levels, compared
to the groups with less consistent LTPA across adulthood. The group
who became active showed better biomarker proﬁles than the
group who became inactive. Associations were only partly atten-
uated following adjustment for a range of covariates, with adjust-
ment for BMI causing the greatest reduction in differences.
4.2. Relation to other studies
Our ﬁndings are consistent with the few other epidemiological
studies that have examined associations between patterns of LTPA
and CVD biomarkers, but over a shorter time period or later in life.
These include ﬁndings that older men from BRHS that maintained
participation in LTPA over up to 20-years follow-up had the lowest
levels of CRP and t-PA, with those least active at both assessment
having the highest levels [16,17]. Our results are also similar to
ﬁndings from the Whitehall II Study, which showed that partici-
pants who were regularly active at all 3 assessments over the 10-
year period had the lowest levels of the pro-inﬂammatory
markers CRP and IL-6 [18]. Likewise, and consistent with our
ﬁndings, CVD outpatients from the Heart and Soul Study, that were
active in LTPA at 5-year follow-up, having also been previouslyactivity across adulthood and biomarkers of cardiovascular disease at
oi.org/10.1016/j.atherosclerosis.2017.11.019
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is important because it shows that LTPA patterns as early as mid-
adulthood were associated with a wide range of CVD biomarkers
28 years later.
4.3. Explanation of ﬁndings
These ﬁndings suggest that long-term LTPA participation may
inﬂuence physiological and biochemical functions of blood vessels
and lend support to an accumulation of additive effects hypothesis
whereby continued exposure to greater LTPA cumulatively beneﬁts
subsequent levels of CVD biomarkers. The endothelium is directly
(and indirectly through effects on other body tissues) involved in
maintaining vascular homeostasis and many of its functions are
responsive to physical activity [9,12e14,28].
CRP and IL-6 are the most well-known pro-inﬂammatory mol-
ecules and at higher concentrations are considered strong pre-
dictors of CVD [29]. Acute exposure to physical activity is known to
increase anti-inﬂammatory and reduce pro-inﬂammatory cyto-
kines which play a main role in arterial stiffening [11,12,14] and our
ﬁndings suggest that minimising the amount of inﬂammatory
response is also one beneﬁt of long-term LTPA. Likewise, t-PA, an
endothelial-speciﬁc glycoprotein critical to ﬁbrinolysis which at
high circulating levels is predictive of CVD [30], appears responsive
to long-term LTPA.
Our ﬁndings also suggest a beneﬁcial effect of long-term LTPA on
leptin in men and women and adiponectin in women only. Leptin
and adiponectin are adipose tissue-based cytokines whose levels
are altered in endothelial dysfunction and which are thought to be
involved in CVD aetiology [31]; increases in adiponectin are pro-
tective and in leptin are damaging to vascular homeostasis [31].
Intervention studies have reported inconsistent relationships be-
tween exercise and adiponectin [8] and our ﬁnding that adulthood
LTPA was related to adiponectin in women only requires investi-
gation in other long-term studies. Likewise, although a weak in-
verse association between greater accumulation of LTPA across
adulthood and lower E-selectin was observed, there was little ev-
idence overall of association between LTPA and E-selectin which is
similar to a review of intervention studies [9].
In the present analyses, adjustment for current BMI resulted in
the greatest attenuation of estimates although it did not fully
explain associations. This suggests that BMI may be one route, but
not the only route, through which LTPA beneﬁts cardiovascular
health [32] and is consistent with studies showing persisting as-
sociations after adjustment for body size [17,18]. Evidence from
longitudinal studies suggests that moderate-to-vigorous physical
activity, which makes up the majority of time spent in LTPA [33],
can help prevent excess body fat [34,35]. Furthermore, the car-
diovascular beneﬁts of LTPA have been shown at all body weights
including overweight and obesity [36] which are established CVD
risk factors [37]. In addition to our current ﬁndings, we recently
showed that longer time spent overweight or obese across life in
NSHD was associated with more adverse levels of inﬂammatory
markers and adipokines at age 60e64 [38] which, in light of our
current ﬁndings, suggest that the beneﬁts of LTPA and BMI on these
biomarkers likely involves one pathway from LTPA through BMI as
well as additional pathways from BMI and from LTPA.
Other effects of physical activity on endothelial function which
have been described include enhanced nitric oxide production
(responsible for vasodilation, lowering peripheral resistance and
increasing perfusion) and reduced concentrations of vasocon-
strictor agents [9,13,14]. It is also possible that LTPA improves
mobilisation of endothelial progenitor cells and mesenchymal stem
cells from bone marrow, both which have the potential for vascular
regeneration and endothelial repair [28]. These ﬁndings along withPlease cite this article in press as: A. Elhakeem, et al., Leisure-time physical
age 60e64: A prospective cohort study, Atherosclerosis (2017), https://dthe associations reported here may explain how long-term partic-
ipation in LTPA contributes to reducing age-related structural
changes seen in atherosclerotic arteries and subsequent CVD risk
[39e41]. For example, taking up or maintaining LTPA over 8 years
was found to be associated with lower arterial stiffness in middle-
aged Swiss adults [39].
4.4. Strengths and limitations
This study has several important strengths. These include the
longitudinal design which results in less susceptibility to reverse
causation and the repeated reporting of LTPA over almost three
decades of adulthood to examine how long-term patterns of LTPA
relate to a wide range of biomarkers of CVD risk. Adjustment for
important and prospectively ascertained covariates, including BMI
and SEP, is another notable strength. However, some limitations
should also be noted. There were a limited number of participants
(n ¼ 120) who became active at age 60e64 having been inactive at
age 36 which may have reduced statistical power to detect differ-
ences by change in LTPA status. Additionally, the categorisation of
LTPA was relatively crude in that it did not differentiate between
higher levels of LTPA (above participating ﬁve or more times/
month). LTPA was self-reported and can be subject to recall and
misclassiﬁcation errors but these type of data are suitable for
providing information on certain activity domains like LTPA [42].
Further, the LTPA measures used here were found to rank NSHD
participants by levels of physical activity similarly to data from
activity monitors [43,44]. Moreover, we only examined LTPA
however, other activity domains such as active transport may be
beneﬁcially related to cardiovascular biomarkers [45] and may
form important components of overall PA.
Residual confounding by earlier BMI could explain why adjust-
ment for current BMI did not fully explain associations; however
current BMI was previously shown to be an adequate proxy for
lifetime BMI in this cohort [46], and adjustment for BMI recorded at
ages 53 and 60e64 had no inﬂuence on ﬁndings. Further, residual
confounding due to other unmeasured factors such as urbanicity/
rurality is possible. Finally, doctor diagnoses were self-reported and
could be prone to errors however, these measures have been vali-
dated against medical records in NSHD and other similar aged co-
horts [47,48].
4.5. Conclusions
This long-term prospective follow-up study of British men and
women found that greater participation in LTPA and maintaining
participation across adulthood were associated with a more
favourable CVD biomarker proﬁle in early old age. These ﬁndings
support an important role for continued long-term participation in
LTPA in the prevention of CVD. Of further importance to public
health interventions is that our ﬁndings suggest that taking up LTPA
in early old age may also have beneﬁts for cardiovascular health.
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